Now accepting early access partners

Validation that moves
at the speed of science.

EVOLV | The Validation Factory

The first AI-native Computer System Validation platform built for GAMP 5, 21 CFR Part 11, and FDA QMSR. Generate compliant URS, automate risk assessment, and govern AI model changes — in minutes, not months.

Request Early Access ▶ Try Live Demo
GAMP 5 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 2025 GMP Annex 11 EU GMP

The Problem

CSV validation still runs on
spreadsheets and email chains.

Life sciences teams spend months on documentation that should take days. Regulatory guidance has changed. Most platforms haven't.

📋

Weeks to generate a URS

Requirements written manually in Word, reviewed in meetings, rewritten after audit findings. No regulatory traceability. No version control. Just documents.

⚠️

Regulations change. VMPs don't.

FDA's QMSR replaced the QSR on February 2, 2026. The PCCP final guidance landed August 2025. Most validation plans still cite rules that no longer exist.

🤖

AI in GxP with no governance

Drug interaction predictors and defect classifiers are being deployed with no PCCP, no change control, no audit trail. FDA inspectors are starting to notice.

The Platform

One platform.
The entire validation lifecycle.

From first requirement to post-market governance — every step compliant, auditable, and powered by AI that knows GAMP 5.

📄

Validation Factory

Generate GAMP 5-compliant URS from plain English. SMART refinement, PCCP verification, UR/FR decomposition, CSA test scripts, and PDF export with e-signature — in one guided workflow. What took days takes minutes.

URS Generation SMART Refinement UR/FR Decomposition CSA Test Scripts PDF + E-Signature
🔄

Change Control

ServiceNow change requests cross-referenced against your system portfolio in real time. GxP classification, GAMP-aware risk calculation using Severity × Occurrence × Detectability, and automatic revalidation flags. No spreadsheet required.

ServiceNow Integration GxP Classification GAMP Risk Matrix Revalidation Flags
🤖

AI Model Governance

Validated AI models treated as GAMP Category 5 assets. PCCP-aware change assessment aligned to FDA final guidance August 2025. Human-in-the-loop approval queue with 21 CFR Part 11 compliant audit trail.

PCCP Assessment HITL Governance FDA Aug 2025 21 CFR Part 11
📊

Portfolio Dashboard

Every system, every site, every phase — one view. RAG status, action items, regulatory due dates. Register new systems with GxP classification and track their full validation journey from plan to monitor. Built for QA Heads and CTOs.

RAG Status System Registry Lifecycle Tracking Multi-Site

See It In Action

Watch EVOLV handle in 4 minutes
what takes your team weeks.

Three real workflows. No voiceover scripts. No slides. Just the platform doing what it's built to do.

Demo 01

Portfolio Dashboard

Your entire validated system landscape — GAMP category, GxP status, risk level, revalidation due dates — in one view. Built for QA Heads and CTOs who need portfolio-wide compliance visibility instantly..

Demo 02

Change Control & GxP Classification

ServiceNow CR received → portfolio cross-reference → GAMP risk calculation → revalidation decision. Automatic.

Demo 03

AI Model Governance

AI model change in a validated system → PCCP assessment → Governance Hub → human-in-the-loop approval → 21 CFR Part 11 audit trail. Built for FDA's final guidance (Aug 2025).

Try the Validation Factory — live, right now.

Generate a real GAMP 5-compliant URS from your own requirement. No login required.

▶ Open Live Demo

Built For

EVOLV speaks the language
of regulated industries.

Whether you're defending a validation package in an inspection or governing 150 systems across 25 sites — EVOLV gives you the records to back it up.

🧪 QA Head · CSV Manager

Stop writing in Word. Start validating.

EVOLV generates, verifies, and manages your entire validation portfolio with a complete audit trail FDA inspectors can review on the spot.

  • URS from plain English in minutes
  • SMART requirements, auto-verified against GAMP 5
  • Full lifecycle tracking — Plan to Monitor
  • Audit-ready PDFs with e-signature

📋 VP Regulatory Affairs

FDA updated the rules. EVOLV already knows.

QMSR is mandatory. PCCP guidance is final. EVOLV cites the right regulations, routes the right changes, and produces the records you need when an inspector walks in.

  • Aligned to FDA PCCP Guidance Aug 18, 2025
  • 21 CFR Part 820 QMSR / ISO 13485:2016
  • SHA-256 tamper-evident audit trail
  • 21 CFR Part 11 electronic records

💻 CTO · CDO

Your AI models are GAMP Cat 5 assets.

EVOLV gives you the governance infrastructure to deploy AI in GxP contexts without regulatory exposure — with a full HITL approval layer and immutable decision records.

  • AI model registry with version history
  • PCCP-aware change assessment
  • Human-in-the-loop governance hub
  • Portfolio-wide RAG visibility

Regulatory Coverage

GAMP 5 (2nd Edition) 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 18, 2025 GMP Annex 11 EU GMP GLP ISO 17025 GDPR 21 CFR Part 820.35 QMSR FDA CSA Guidance 2022

Early Access

Join our first cohort of life sciences partners.

We're working with a small group of pharma and biotech companies before general availability. Early access partners get priority onboarding, direct access to the founding team, and founding-tier pricing locked in permanently.

🔒  We'll respond within 1 business day. Your information is never shared.

How EvoLV is Pioneering Biotech Consultancy Services in Eastvale

Mar 14, 2025

Introduction to EvoLV's Biotech Consultancy

EvoLV is making waves in the biotech consultancy industry, particularly in Eastvale, thanks to its innovative approach and deep understanding of the sector. As biotechnology continues to evolve at a rapid pace, organizations require expert guidance to navigate complex challenges and seize opportunities. EvoLV stands out as a leader by offering tailored solutions that drive success.

biotech consulting

Comprehensive Services Tailored for Biotech Companies

One of the primary reasons EvoLV has become a pioneering force in Eastvale is its wide range of services designed specifically for biotech companies. These services include strategic planning, regulatory compliance, market analysis, and product development support. By customizing each service to meet the unique needs of their clients, EvoLV ensures that businesses can achieve their goals efficiently and effectively.

Moreover, EvoLV's team of experts brings a wealth of knowledge and experience to the table, allowing them to provide actionable insights and strategies. This personalized approach not only helps companies overcome hurdles but also positions them for long-term growth.

Regulatory Compliance Expertise

Navigating the regulatory landscape is one of the most challenging aspects of the biotech industry. EvoLV excels in this area by offering in-depth expertise in compliance with national and international regulations. Their consultants work closely with clients to ensure that all products meet the necessary standards, thereby reducing the risk of costly delays or penalties.

regulatory compliance

Embracing Innovation to Drive Success

Innovation is at the core of EvoLV's consultancy services. The company is committed to staying ahead of industry trends and incorporating the latest technological advancements into their offerings. By leveraging cutting-edge tools and methodologies, EvoLV helps clients enhance their research and development processes, improve operational efficiency, and bring products to market faster.

Furthermore, EvoLV's focus on innovation extends to their internal practices as well. The company fosters a culture of continuous learning and adaptation, ensuring that their team is always equipped with the most up-to-date knowledge and skills to serve their clients effectively.

Strategic Partnerships and Collaborations

Another key factor in EvoLV's success is their emphasis on strategic partnerships and collaborations. By building strong relationships with academic institutions, research organizations, and industry leaders, EvoLV creates a robust network that benefits their clients. These collaborations not only provide access to additional resources and expertise but also open up new opportunities for growth and innovation.

strategic partnerships

Commitment to Community and Sustainability

EvoLV is deeply committed to contributing positively to the Eastvale community and promoting sustainable practices within the biotech industry. The company actively participates in local initiatives and supports educational programs aimed at nurturing the next generation of biotech professionals.

In addition, EvoLV integrates sustainability into its consultancy services by guiding clients toward environmentally responsible practices. This commitment not only enhances their reputation but also helps foster a more sustainable future for the entire industry.

The Future of Biotech Consultancy in Eastvale

As EvoLV continues to expand its presence in Eastvale, the future looks bright for biotech companies seeking expert consultancy services. The company's pioneering approach and dedication to excellence set a high standard for the industry, ensuring that their clients remain competitive in a rapidly changing landscape.

In conclusion, EvoLV's innovative solutions, regulatory expertise, strategic partnerships, and commitment to sustainability make it a leader in biotech consultancy services. As they continue to grow and adapt, EvoLV is poised to shape the future of biotechnology in Eastvale and beyond.